Global Whole Blood Coagulometers Market Growth 2024-2030

Global Whole Blood Coagulometers Market Growth 2024-2030

A whole blood coagulometer is an analyzer used to test the coagulation efficiency of blood so as to diagnose and assess bleeding disorders such as hemophilia or to monitor patients who are taking anticoagulant medicines such as aspirin, heparin, or warfarin.

The global Whole Blood Coagulometers market size is projected to grow from US$ 4180.1 million in 2023 to US$ 7859.9 million in 2030; it is expected to grow at a CAGR of 9.4% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Whole Blood Coagulometers Industry Forecast” looks at past sales and reviews total world Whole Blood Coagulometers sales in 2023, providing a comprehensive analysis by region and market sector of projected Whole Blood Coagulometers sales for 2024 through 2030. With Whole Blood Coagulometers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Whole Blood Coagulometers industry.

This Insight Report provides a comprehensive analysis of the global Whole Blood Coagulometers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Whole Blood Coagulometers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Whole Blood Coagulometers market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Whole Blood Coagulometers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Whole Blood Coagulometers.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. Rising incidences of cardiovascular diseases and blood disorders are likely to have a significant impact on the coagulation analyzers market during the forecast period 2022 to 2029. Another important factor driving the expanding usage of coagulation analyzers is growing geriatric population, rising healthcare costs, technological developments, and rising obesity rates. On the other hand, emerging markets and growing reagent rental business will provide significant opportunities for the growth of the coagulation analyzer market throughout the forecast period. Key market players have launched innovative analyzers that are small in size and easy to integrate, triggering the demand for such analyzers to be widely used in various medical facilities. Furthermore, rising awareness in healthcare systems in many parts of the world has also increased the demand for such analyzers. The rapid advancement and optimization of testing facilities is also driving the growth of the industry as a whole. The subsequent proliferation of innovative healthcare facilities, treatment centers, laboratory facilities, and academic institutions has resulted in a significant increase in the demand for such analyzers. Due to the rising number of heart disease and blood disorders, the demand for these analyzers is also increasing. Due to the ease of use and performance features of these analyzers, patients are able to use these analyzers at home to assess their coagulation status. The aforementioned factors are expected to boost the global market growth.

This report presents a comprehensive overview, market shares, and growth opportunities of Whole Blood Coagulometers market by product type, application, key manufacturers and key regions and countries.

Segmentation by type


Standalone Analysers

Table Top Analysers

Portable Analysers
Segmentation by application


Hospitals

Clinical Laboratories

Others
This report also splits the market by region:


Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.


Siemens

Instrumentation Laboratory

Roche

Mindray

MRC

Perosphere Technologies

Helena Laboratories

Thermo Fisher Scientific

ERBA Diagnostics Mannheim

Rayto Life and Analytical Sciences

Nihon Kohden Corporation

Beckman Coulter Inc. (Danaher Corporation)

Abbott Laboratories

HORIBA Medical

DIRUI Industrial

Seleo

Zircon Biotech

Beijing Succeeder Technology
Key Questions Addressed in this Report

What is the 10-year outlook for the global Whole Blood Coagulometers market?

What factors are driving Whole Blood Coagulometers market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Whole Blood Coagulometers market opportunities vary by end market size?

How does Whole Blood Coagulometers break out type, application?


Please note: The report will take approximately 2 business days to prepare and deliver.